K012371

Substantially Equivalent

TINA-QUANT TRANSFERRIN VER.2

Applicant: Roche Diagnostics Corp.
Product code: DDG
Advisory panel: Immunology
Date received: 2001-07-26
Decision date: 2001-09-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.